Quick Answer
Stemtech Corp reported Operating Income Loss of -$2.39 million for the year ending 2024.
- Stemtech Corp showed an increase of +43.5% in Operating Income Loss from 2023 to 2024.
- This data is from Stemtech Corp's annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2012 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2024), Stemtech Corp's Operating Income Loss has declined by 8,559.3%.
- Historical annual values: Fiscal year 2024: -$2.39 million | Fiscal year 2023: -$4.22 million | Fiscal year 2022: -$5.02 million | Fiscal year 2021: -$3.21 million | Fiscal year 2020: -$1.43 million | Fiscal year 2020: -$18.9 thousand | Fiscal year 2019: -$20.2 thousand | Fiscal year 2018: -$24.8 thousand | Fiscal year 2017: -$36.5 thousand | Fiscal year 2016: -$23.5 thousand | Fiscal year 2015: -$16.6 thousand | Fiscal year 2014: -$35.3 thousand | Fiscal year 2013: -$28.6 thousand | Fiscal year 2012: -$27.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: